Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | -0.63% | +8.22% | -3.07% |
Jun. 05 | InflaRx N.V. Hosts R&D Event Highlighting the Promise of INF904 | CI |
May. 08 | InflaRx N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on InflaRx N.V.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering InflaRx N.V.
HC Wainwright | |
Raymond James | |
Guggenheim | |
LifeSci Capital | |
SVB Securities LLC | |
SVB Leerink | |
Credit Suisse |
EPS Revisions
- Stock Market
- Equities
- IFRX Stock
- Consensus InflaRx N.V.